Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer’s-like cognitive decline-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer’s-like cognitive decline

Published:2014-02-03 Issue:3 Volume:124 Page:1000-1012
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Bernstein Kenneth E.,Koronyo Yosef,Salumbides Brenda C.,Sheyn Julia,Pelissier Lindsey,Lopes Dahabada H.J.,Shah Kandarp H.,Bernstein Ellen A.,Fuchs Dieu-Trang,Yu Jeff J.-Y.,Pham Michael,Black Keith L.,Shen Xiao Z.,Fuchs Sebastien,Koronyo-Hamaoui Maya

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference79 articles.

1. National estimates of the prevalence of Alzheimer's disease in the United States

2. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

3. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

4. Quantification of the Aβ peptide in Alzheimer's plaques by laser dissection microscopy combined with mass spectrometry

5. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of angiotensin converting enzyme in pathogenesis associated with immunity in cardiovascular diseases;Life Sciences;2024-09

2. Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?;Translational Neurodegeneration;2024-08-19

3. Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function;Journal of Biological Chemistry;2024-06

4. Angiotensin Converting Enzyme (ACE) expression in microglia reduces amyloid β deposition and neurodegeneration by increasing SYK signaling and endolysosomal trafficking;2024-04-28

5. Mathematical modelling of Alzheimer’s disease biomarkers: Targeting Amyloid beta, Tau protein, Apolipoprotein E and Apoptotic pathways;American Journal of Translational Research;2024